openPR Logo
Press release

Topical Treatment, Light Therapy, And Systemic Medication Based By Psoriasis Market With Focus On Plaque Psoriasis 2016-20

12-14-2016 04:34 PM CET | Health & Medicine

Press release from: Psoriasis

"Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.

Description-

Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It is an autoimmune disease and may be triggered by smoking, alcohol consumption, cold or dry weather and stress.

Get Sample Report With TOC @ https://goo.gl/qnnp3S

In the wake of lesser treatment options and costly therapies, psoriasis remains as an under treated disease. Psoriasis treatment can be divided into three main groups: topical treatment, light therapy, and systemic medication based on the severity of the disease. The typical treatment options include TNF inhibitors and IL inhibitors. However, various therapies and drugs are in the pipeline and it is expected that treatment options will improve over time with higher efficacy and lower costs.
The global market for psoriasis has been increasing consistently over the last few years. The major factors contributing to the growth of the global psoriasis market are increasing smoking and alcohol consumption trends globally. Surging smoking population, increased spending on medicines, increasing sales of prescription drugs and escalating health care expenditure are the key growth drivers of the market. However, growth of the market is hindered by extensive drug development and approval process and side-effects associated with the existing medication for psoriasis.

Table of Content
1. Market Overview
1.1 Psoriasis    
1.2 Types    
1.2.1 Plaque Psoriasis    
1.2.2 Guttate Psoriasis    
1.2.3 Inverse Psoriasis    
1.2.4 Pustular Psoriasis    
1.2.5 Erytherodermic Psoriasis    
1.3 Causes    
1.4 Symptoms by Types    
1.4.1 Plaque Psoriasis    
1.4.2 Guttate Psoriasis    
1.4.3 Inverse Psoriasis    
1.4.4 Pustular Psoriasis    
1.4.5 Erytherodermic Psoriasis    
1.5 Diagnosis    
1.6 Treatment Options    
1.6.1 Topical Treatments    
1.6.2 Light Therapy or Phototherapy    
1.6.3 Systemic Treatments
2. Global Market
2.1 Global Psoriasis Market by Value    
2.2 Global Psoriasis Market by Therapy
3. The US Market
3.1 Autoimmune Disease Market    
3.1.1 The US Autoimmune Disease Market by Value    
3.2 Psoriasis Market    
3.2.1 The US Psoriasis Prevalence    
3.2.2 The US Psoriasis Market by Value    
3.2.3 The US Psoriasis Market by Treatment    
3.2.4 The US Psoriasis IL-Inhibitors Market by Value    
3.3 Plaque Psoriasis Market    

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Researchmoz Global Pvt. Ltd.
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Topical Treatment, Light Therapy, And Systemic Medication Based By Psoriasis Market With Focus On Plaque Psoriasis 2016-20 here

News-ID: 395957 • Views:

More Releases from Psoriasis

Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020
ALBANY, NY, March 1, 2017 : ResearchMoz presents professional and in-depth study of "Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020". Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up
Psoriasis - 5EU Drug Forecast And Market Analysis To 2024
Psoriasis - 5EU Drug Forecast and Market Analysis to 2024 Access Report: http://www.marketresearchreports.biz/analysis/754851 Summary Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. Specifically, adult plaque psoriasis, the most common form of Psoriasis, is the focus of this report. Although not life-threatening, Psoriasis causes tremendous morbidity and personal angst for patients. GlobalData projects the Psoriasis market in 8MM to experience modest growth during the

More Releases for Psoriasis  

Prevalence Of Psoriasis Driving Market Growth: A Key Catalyst Accelerating Psori …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025? Over the recent years, there has been a robust growth in the size of the psoriasis market. It is estimated to rise from $26.45 billion in 2024 to $28.93 billion in 2025, with a compound annual
Psoriasis Vulgaris Market
Introduction Psoriasis vulgaris, also known as plaque psoriasis, is the most common form of psoriasis, accounting for nearly 80-90% of all cases. It is a chronic autoimmune condition marked by red, scaly plaques that can cause significant physical discomfort and emotional distress. Affecting millions worldwide, psoriasis vulgaris is increasingly recognized as both a dermatological and systemic disease due to its association with arthritis, cardiovascular disease, and metabolic syndrome. The global psoriasis vulgaris
Major Growth Driver Identified in 2025 Psoriasis Market: Prevalence Of Psoriasis …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the size of the psoriasis market has experienced a significant increase. It is projected to escalate from $26.56 billion in 2024 to $29.5 billion in 2025, reflecting a compound annual growth rate (CAGR)
Prevalence Of Psoriasis Driving Market Growth: Key Factor Driving The Growth In …
The Psoriasis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Psoriasis Market Size During the Forecast Period? The psoriasis market has seen rapid growth in recent years. It will increase from $26.56 billion in 2024 to $29.5 billion in 2025, at a
Plaque Psoriasis to Hold 85% Share of Psoriasis Drugs Market through 2031
Psoriasis is a chronic inflammatory skin disease that occurs due to genetic disposition and environmental factors. Psoriasis is a systemic disease associated with psychological, metabolic, arthritic, and cardiovascular comorbidities. On an average, psoriasis affects around 2 - 3% of the population globally. Plaque psoriasis, being the number one and most common indication, held nearly 85% share of the US$ 11.37 Bn psoriasis drugs market in 2021, with the market estimated to
Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020
Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It